Moisand Fitzgerald Tamayo’s GSK GSK Stock Holding History

Moisand Fitzgerald Tamayo’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-321	Closed	-$11.3K	–	789
2022 Q4	$11.3K	Hold	321	–	–	﹤0.01%	304
2022 Q3	$9K	Sell	321 -1	-0.3%	-$38	﹤0.01%	293
2022 Q2	$17K	Hold	322	–	–	﹤0.01%	237
2022 Q1	$18K	Hold	322	–	–	0.01%	141
2021 Q4	$18K	Hold	322	–	–	0.01%	211
2021 Q3	$15K	Hold	322	–	–	0.01%	217
2021 Q2	$16K	Hold	322	–	–	0.01%	222
2021 Q1	$14K	Hold	322	–	–	0.01%	190
2020 Q4	$15K	Hold	322	–	–	0.01%	187
2020 Q3	$15K	Hold	322	–	–	0.01%	173
2020 Q2	$16K	Sell	322 -20	-6%	-$1.03K	0.01%	163
2020 Q1	$16K	Hold	342	–	–	0.01%	158
2019 Q4	$20K	Hold	342	–	–	0.01%	162
2019 Q3	$18K	Hold	342	–	–	0.01%	162
2019 Q2	$17K	Hold	342	–	–	0.01%	166
2019 Q1	$18K	Hold	342	–	–	0.01%	164
2018 Q4	$16K	Hold	342	–	–	0.01%	166
2018 Q3	$17K	Hold	342	–	–	0.01%	180
2018 Q2	$17K	Hold	342	–	–	0.01%	165
2018 Q1	$17K	Hold	342	–	–	0.01%	175
2017 Q4	$15K	Hold	342	–	–	0.01%	174
2017 Q3	$17K	Buy	+342	New	+$17.4K	0.01%	173
2016 Q2	–	Sell	-614	Closed	-$31K	–	108
2016 Q1	$31K	Hold	614	–	–	0.03%	112
2015 Q4	$31K	Buy	+614	New	+$31.3K	0.03%	106

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Moisand Fitzgerald Tamayo's GSK Position: Q1 2023 in Review

Moisand Fitzgerald Tamayo sold out of GSK (GSK) in Q1 2023, closing a stake of 321 shares — an estimated $11.3K sold.

Moisand Fitzgerald Tamayo first reported a position in GSK in Q4 2015 and held it in 24 quarters. The position peaked at $31K in Q1 2016. 809 funds tracked by Wall St. Rank hold GSK as of Q1 2023.

Moisand Fitzgerald Tamayo reported no remaining GSK position as of Q1 2023 after selling out during the quarter.
Moisand Fitzgerald Tamayo sold 321 GSK shares in Q1 2023, an estimated $11.3K.
Moisand Fitzgerald Tamayo first reported a position in GSK in Q4 2015 and held it in 24 quarters.
Moisand Fitzgerald Tamayo's GSK position peaked at $31K in Q1 2016.
809 funds tracked by Wall St. Rank held GSK as of Q1 2023.

Based on Moisand Fitzgerald Tamayo's 13F filing for Q1 2023, filed 5 May 2023.